The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Single-Use Technology for Biopharmaceuticals Market Research Report 2024
Synopsis
A biopharmaceutical is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.
The global Single-Use Technology for Biopharmaceuticals market was valued at US$ 4328.7 million in 2023 and is anticipated to reach US$ 8472.9 million by 2030, witnessing a CAGR of 9.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Single-Use Technology for Biopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single-Use Technology for Biopharmaceuticals.
Report Scope
The Single-Use Technology for Biopharmaceuticals market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Single-Use Technology for Biopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single-Use Technology for Biopharmaceuticals companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Applikon Biotechnology
BioPure Technology
DowDuPont
EMD Millipore
GE Healthcare
Novasep
Pall
Saint-Gobain
Sartorius
Thermo Fisher Scientific
W. L. Gore and Associates
Segment by Type
Protective Clothing
Syringes
Pipettes and Pipette Tips
Flasks, Dishes, Sample and Centrifuge Vials
Simple Cultivation Systems
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single-Use Technology for Biopharmaceuticals companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A biopharmaceutical is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources.
The global Single-Use Technology for Biopharmaceuticals market was valued at US$ 4328.7 million in 2023 and is anticipated to reach US$ 8472.9 million by 2030, witnessing a CAGR of 9.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Single-Use Technology for Biopharmaceuticals, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single-Use Technology for Biopharmaceuticals.
Report Scope
The Single-Use Technology for Biopharmaceuticals market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Single-Use Technology for Biopharmaceuticals market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Single-Use Technology for Biopharmaceuticals companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Applikon Biotechnology
BioPure Technology
DowDuPont
EMD Millipore
GE Healthcare
Novasep
Pall
Saint-Gobain
Sartorius
Thermo Fisher Scientific
W. L. Gore and Associates
Segment by Type
Protective Clothing
Syringes
Pipettes and Pipette Tips
Flasks, Dishes, Sample and Centrifuge Vials
Simple Cultivation Systems
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Single-Use Technology for Biopharmaceuticals companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Single-Use Technology for Biopharmaceuticals Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Protective Clothing
1.2.3 Syringes
1.2.4 Pipettes and Pipette Tips
1.2.5 Flasks, Dishes, Sample and Centrifuge Vials
1.2.6 Simple Cultivation Systems
1.3 Market by Application
1.3.1 Global Single-Use Technology for Biopharmaceuticals Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Single-Use Technology for Biopharmaceuticals Market Perspective (2019-2030)
2.2 Single-Use Technology for Biopharmaceuticals Growth Trends by Region
2.2.1 Global Single-Use Technology for Biopharmaceuticals Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Single-Use Technology for Biopharmaceuticals Historic Market Size by Region (2019-2024)
2.2.3 Single-Use Technology for Biopharmaceuticals Forecasted Market Size by Region (2025-2030)
2.3 Single-Use Technology for Biopharmaceuticals Market Dynamics
2.3.1 Single-Use Technology for Biopharmaceuticals Industry Trends
2.3.2 Single-Use Technology for Biopharmaceuticals Market Drivers
2.3.3 Single-Use Technology for Biopharmaceuticals Market Challenges
2.3.4 Single-Use Technology for Biopharmaceuticals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Single-Use Technology for Biopharmaceuticals Players by Revenue
3.1.1 Global Top Single-Use Technology for Biopharmaceuticals Players by Revenue (2019-2024)
3.1.2 Global Single-Use Technology for Biopharmaceuticals Revenue Market Share by Players (2019-2024)
3.2 Global Single-Use Technology for Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Single-Use Technology for Biopharmaceuticals Revenue
3.4 Global Single-Use Technology for Biopharmaceuticals Market Concentration Ratio
3.4.1 Global Single-Use Technology for Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Single-Use Technology for Biopharmaceuticals Revenue in 2023
3.5 Single-Use Technology for Biopharmaceuticals Key Players Head office and Area Served
3.6 Key Players Single-Use Technology for Biopharmaceuticals Product Solution and Service
3.7 Date of Enter into Single-Use Technology for Biopharmaceuticals Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Single-Use Technology for Biopharmaceuticals Breakdown Data by Type
4.1 Global Single-Use Technology for Biopharmaceuticals Historic Market Size by Type (2019-2024)
4.2 Global Single-Use Technology for Biopharmaceuticals Forecasted Market Size by Type (2025-2030)
5 Single-Use Technology for Biopharmaceuticals Breakdown Data by Application
5.1 Global Single-Use Technology for Biopharmaceuticals Historic Market Size by Application (2019-2024)
5.2 Global Single-Use Technology for Biopharmaceuticals Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Single-Use Technology for Biopharmaceuticals Market Size (2019-2030)
6.2 North America Single-Use Technology for Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Single-Use Technology for Biopharmaceuticals Market Size by Country (2019-2024)
6.4 North America Single-Use Technology for Biopharmaceuticals Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Single-Use Technology for Biopharmaceuticals Market Size (2019-2030)
7.2 Europe Single-Use Technology for Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Single-Use Technology for Biopharmaceuticals Market Size by Country (2019-2024)
7.4 Europe Single-Use Technology for Biopharmaceuticals Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Single-Use Technology for Biopharmaceuticals Market Size (2019-2030)
8.2 Asia-Pacific Single-Use Technology for Biopharmaceuticals Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Single-Use Technology for Biopharmaceuticals Market Size by Region (2019-2024)
8.4 Asia-Pacific Single-Use Technology for Biopharmaceuticals Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Single-Use Technology for Biopharmaceuticals Market Size (2019-2030)
9.2 Latin America Single-Use Technology for Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Single-Use Technology for Biopharmaceuticals Market Size by Country (2019-2024)
9.4 Latin America Single-Use Technology for Biopharmaceuticals Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size (2019-2030)
10.2 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size by Country (2019-2024)
10.4 Middle East & Africa Single-Use Technology for Biopharmaceuticals Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Applikon Biotechnology
11.1.1 Applikon Biotechnology Company Detail
11.1.2 Applikon Biotechnology Business Overview
11.1.3 Applikon Biotechnology Single-Use Technology for Biopharmaceuticals Introduction
11.1.4 Applikon Biotechnology Revenue in Single-Use Technology for Biopharmaceuticals Business (2019-2024)
11.1.5 Applikon Biotechnology Recent Development
11.2 BioPure Technology
11.2.1 BioPure Technology Company Detail
11.2.2 BioPure Technology Business Overview
11.2.3 BioPure Technology Single-Use Technology for Biopharmaceuticals Introduction
11.2.4 BioPure Technology Revenue in Single-Use Technology for Biopharmaceuticals Business (2019-2024)
11.2.5 BioPure Technology Recent Development
11.3 DowDuPont
11.3.1 DowDuPont Company Detail
11.3.2 DowDuPont Business Overview
11.3.3 DowDuPont Single-Use Technology for Biopharmaceuticals Introduction
11.3.4 DowDuPont Revenue in Single-Use Technology for Biopharmaceuticals Business (2019-2024)
11.3.5 DowDuPont Recent Development
11.4 EMD Millipore
11.4.1 EMD Millipore Company Detail
11.4.2 EMD Millipore Business Overview
11.4.3 EMD Millipore Single-Use Technology for Biopharmaceuticals Introduction
11.4.4 EMD Millipore Revenue in Single-Use Technology for Biopharmaceuticals Business (2019-2024)
11.4.5 EMD Millipore Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Detail
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Single-Use Technology for Biopharmaceuticals Introduction
11.5.4 GE Healthcare Revenue in Single-Use Technology for Biopharmaceuticals Business (2019-2024)
11.5.5 GE Healthcare Recent Development
11.6 Novasep
11.6.1 Novasep Company Detail
11.6.2 Novasep Business Overview
11.6.3 Novasep Single-Use Technology for Biopharmaceuticals Introduction
11.6.4 Novasep Revenue in Single-Use Technology for Biopharmaceuticals Business (2019-2024)
11.6.5 Novasep Recent Development
11.7 Pall
11.7.1 Pall Company Detail
11.7.2 Pall Business Overview
11.7.3 Pall Single-Use Technology for Biopharmaceuticals Introduction
11.7.4 Pall Revenue in Single-Use Technology for Biopharmaceuticals Business (2019-2024)
11.7.5 Pall Recent Development
11.8 Saint-Gobain
11.8.1 Saint-Gobain Company Detail
11.8.2 Saint-Gobain Business Overview
11.8.3 Saint-Gobain Single-Use Technology for Biopharmaceuticals Introduction
11.8.4 Saint-Gobain Revenue in Single-Use Technology for Biopharmaceuticals Business (2019-2024)
11.8.5 Saint-Gobain Recent Development
11.9 Sartorius
11.9.1 Sartorius Company Detail
11.9.2 Sartorius Business Overview
11.9.3 Sartorius Single-Use Technology for Biopharmaceuticals Introduction
11.9.4 Sartorius Revenue in Single-Use Technology for Biopharmaceuticals Business (2019-2024)
11.9.5 Sartorius Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Detail
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Single-Use Technology for Biopharmaceuticals Introduction
11.10.4 Thermo Fisher Scientific Revenue in Single-Use Technology for Biopharmaceuticals Business (2019-2024)
11.10.5 Thermo Fisher Scientific Recent Development
11.11 W. L. Gore and Associates
11.11.1 W. L. Gore and Associates Company Detail
11.11.2 W. L. Gore and Associates Business Overview
11.11.3 W. L. Gore and Associates Single-Use Technology for Biopharmaceuticals Introduction
11.11.4 W. L. Gore and Associates Revenue in Single-Use Technology for Biopharmaceuticals Business (2019-2024)
11.11.5 W. L. Gore and Associates Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
